The efficacy of anti-EGFR therapy in treating metastatic colorectal cancer differs between the middle/low rectum and the left-sided colon

BACKGROUND: Clinically, metastatic rectal cancer has been considered a subset of left-sided colon cancer. However, heterogeneity has been proposed to exist between high and middle/low rectal cancers. We aimed to examine the efficacy of anti-epidermal growth factor receptor (EGFR) treatment for middl...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Kun-Han, Chen, Wei-Shone, Jiang, Jeng-Kai, Yang, Shung-Haur, Wang, Huann-Sheng, Chang, Shih-Ching, Lan, Yuan-Tzu, Lin, Chun-Chi, Lin, Hung-Hsin, Huang, Sheng-Chieh, Cheng, Hou-Hsuan, Chao, Yee, Teng, Hao-Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437976/
https://www.ncbi.nlm.nih.gov/pubmed/34188197
http://dx.doi.org/10.1038/s41416-021-01470-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437976/
https://www.ncbi.nlm.nih.gov/pubmed/34188197
http://dx.doi.org/10.1038/s41416-021-01470-2

Ejemplares similares